Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations (2018)
Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF
Subjects: DOENÇAS METABÓLICAS, POLIMORFISMO, FARMACOGENÉTICA
ABNT
HIRATA, Rosario Dominguez Crespo et al. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations. Brazilian Journal of Pharmaceutical Sciences, v. 54, p. 1-25 art. e01005, 2018Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902018000001005. Acesso em: 03 set. 2024.APA
Hirata, R. D. C., Cerda, A., Genvigir, F. D. V., & Hirata, M. H. (2018). Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations. Brazilian Journal of Pharmaceutical Sciences, 54, 1-25 art. e01005. doi:10.1590/s2175-97902018000001005NLM
Hirata RDC, Cerda A, Genvigir FDV, Hirata MH. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 1-25 art. e01005.[citado 2024 set. 03 ] Available from: https://doi.org/10.1590/s2175-97902018000001005Vancouver
Hirata RDC, Cerda A, Genvigir FDV, Hirata MH. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 1-25 art. e01005.[citado 2024 set. 03 ] Available from: https://doi.org/10.1590/s2175-97902018000001005